Cardiovascular Systems Inc (CSII)

Overview

Cardiovascular Systems, Inc. (CSI) is a pioneering medical technology firm committed to the development and commercialization of cutting-edge therapeutic solutions aimed at addressing peripheral and coronary artery diseases. With a dedication to enhancing patient outcomes, CSI serves both domestic and international markets. The company offers a spectrum of catheter-based systems specified for the treatment of peripheral artery disease (PAD), a condition that prompts the accumulation of arterial plaque, notably severe calcifications in arteries near the knee. Additionally, CSI provides complementary peripheral support products.

In the realm of coronary artery disease (CAD), CSI features the Diamondback 360 Coronary Orbital Atherectomy System (OAS), a specialized device designed to facilitate the successful placement of stents in patients with heavily calcified lesions. These patients are candidates for less invasive procedures such as percutaneous transluminal coronary angioplasty or stenting. To support these advanced therapies, CSI produces and supplies various procedural accessories including guidewires, catheters, balloons, and embolic protection systems. The company is also engaged in a partnership with Chansu Vascular Technologies, LLC, to develop innovative everolimus drug-coated balloons for both peripheral and coronary therapeutic applications. Originally established in 1989 as Shturman Cardiology Systems, Inc., CSI officially transitioned to its current name in January 2003 and is headquartered in Saint Paul, Minnesota.

Products and Services

• Catheter-Based Systems for Peripheral Artery Disease (PAD)

  CSI provides a diverse array of catheter-based systems designed to tackle various types of arterial plaque, especially those that are significantly calcified. These systems focus on treating affected arteries both above and below the knee and aim to offer better clinical outcomes compared to traditional surgical, interventional, and therapeutic approaches.

• Diamondback 360 Coronary Orbital Atherectomy System (OAS)

  This specialized device is engineered to assist in the effective placement of stents in CAD patients exhibiting heavily calcified coronary artery lesions. The OAS facilitates percutaneous transluminal coronary angioplasty or stenting procedures, aiming to provide better results for patients requiring intervention due to coronary artery disease.

• Peripheral Support Products

  In addition to its main catheter-based systems, CSI offers various supplementary products that provide support during peripheral artery treatments, enhancing the effectiveness and safety of procedures.

• Procedural Accessories

  CSI manufactures and distributes essential accessories critical for medical procedures. These include guidewires, catheters, balloons, and embolic protection systems, all of which ensure smooth and efficient operations during interventions.

• Everolimus Drug-Coated Balloons

  In collaboration with Chansu Vascular Technologies, LLC, CSI is developing innovative everolimus drug-coated balloons intended for use in both peripheral and coronary medical applications, serving to enhance therapeutic outcomes through drug delivery mechanisms.